Pfizer CEO Albert Bourla on AI and the future of medicine
Pfizer Chairman and CEO Albert Bourla joined Frederick Kempe to discuss how artificial intelligence is transforming the healthcare industry. From drug discovery to clinical research and beyond, they explore the opportunities and challenges ahead. Bourla also addresses the role business and government play in ensuring innovation keeps pace with rapid technological advances.
This conversation took place during the Atlantic Council’s #ACinNY programming on the sidelines of the United Nations General Assembly.
Listen to Inflection Points with Frederick Kempe wherever you get podcasts
About the podcast
Hosted by Frederick Kempe, president and CEO of the Atlantic Council and long-time Wall Street Journal editor and reporter, each episode goes beyond the headlines to explore the forces driving geopolitics, economics, technological change, and global leadership.
Drawing on Kempe’s decades of experience as a journalist, author, and historian, as well as his personal relationships with many of today’s key decisionmakers, Inflection Points with Frederick Kempe offers intimate, substantive conversations with global leaders and influential thinkers on the inflection points transforming the world.
Image: AC in NY ACFP - Pfizer's Albert Bourla on AI, health and innovation in a changing world on September 22, 2026 at The St. Regis New York. Photography by Clarissa Villondo www.clarissavillondo.com